Tensin3 Rabbit Polyclonal Antibody

Function:May play a role in actin remodeling. Involved in the dissociation of the integrin-tensin-actin complex. EGF activates TNS4 and down-regulates TNS3 which results in capping the tail of ITGB1. Seems to be involved in mammary cell migration. May be involved in cell migration and bone development., induction:EGF induces down-regulation., PTM:Epidermal growth factor (EGF) induces tyrosine phosphorylation in a time- and dose-dependent manner., similarity:Contains 1 C2 tensin-type domain., similarity:Contains 1 phosphatase tensin-type domain., similarity:Contains 1 SH2 domain., subunit:EGF promotes the interaction with EGFR. Interacts with PTK2 and BCAR1. Tyrosine phosphorylation is critical for these interactions., tissue specificity:Expressed in umbilical vein endothelial cells, epithelial cells, and fibroblasts cells (at protein level) . Highly expressed in thyroid, kidney and placenta. Low expression in heart, skeletal muscle, spleen, liver, and lung. Expressed in tumor endothelial cells. Expression seems to be down-regulated in thyroid tumor tissues and in anaplastic carcinomas., function:May play a role in actin remodeling. Involved in the dissociation of the integrin-tensin-actin complex. EGF activates TNS4 and down-regulates TNS3 which results in capping the tail of ITGB1. Seems to be involved in mammary cell migration. May be involved in cell migration and bone development., induction:EGF induces down-regulation., PTM:Epidermal growth factor (EGF) induces tyrosine phosphorylation in a time- and dose-dependent manner., similarity:Contains 1 C2 tensin-type domain., similarity:Contains 1 phosphatase tensin-type domain., similarity:Contains 1 SH2 domain., subunit:EGF promotes the interaction with EGFR. Interacts with PTK2 and BCAR1. Tyrosine phosphorylation is critical for these interactions., tissue specificity:Expressed in umbilical vein endothelial cells, epithelial cells, and fibroblasts cells (at protein level) . Highly expressed in thyroid, kidney and placenta. Low expression in heart, skeletal muscle, spleen, liver, and lung. Expressed in tumor endothelial cells. Expression seems to be down-regulated in thyroid tumor tissues and in anaplastic carcinomas.